Inventor
PELLICCIARI ROBERTO
IT67 patents
⚠️ This page may combine multiple inventors who share the name “PELLICCIARI ROBERTO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
INTERCEPT PHARMACEUTICALS INC
26 patentsUS9763964B2Sep 19, 2017
Bile acid derivatives as FXR ligands for the prevention or treatment of FXR-mediated diseases or conditions
INTERCEPT PHARMACEUTICALS INC23 citations93
US8377916B2Feb 19, 2013
Steroids as agonists for FXR
INTERCEPT PHARMACEUTICALS INC15 citations93
US7812011B2Oct 12, 2010
Steroid agonist for FXR
INTERCEPT PHARMACEUTICALS INC18 citations93
US7786102B2Aug 31, 2010
Steroids as agonists for FXR
INTERCEPT PHARMACEUTICALS INC20 citations93
US7994352B2Aug 9, 2011
Process for preparing 3a(β)-7a(β)-dihydroxy-6a(β)-alkyl-5β-cholanic acid
INTERCEPT PHARMACEUTICALS INC22 citations92
US7932244B2Apr 26, 2011
Bile acid derivatives as FXR ligands for the prevention or treatment of FXR-mediated diseases or conditions
INTERCEPT PHARMACEUTICALS INC24 citations92
US7858608B2Dec 28, 2010
Bile acid derivatives as FXR ligands for the prevention or treatment of FXR-mediated diseases or conditions
INTERCEPT PHARMACEUTICALS INC21 citations92
US10532061B2Jan 14, 2020
Farnesoid X receptor modulators
INTERCEPT PHARMACEUTICALS INC5 citations84
US9732117B2Aug 15, 2017
Steroids as agonists for FXR
INTERCEPT PHARMACEUTICALS INC3 citations84
US9650409B2May 16, 2017
TGR5 modulators and methods of use thereof
INTERCEPT PHARMACEUTICALS INC4 citations84
US9611289B2Apr 4, 2017
Farnesoid X receptor modulators
INTERCEPT PHARMACEUTICALS INC13 citations84
US10421772B2Sep 24, 2019
Steroids as agonists for FXR
INTERCEPT PHARMACEUTICALS INC1 citations73
US9540414B2Jan 10, 2017
TGR5 modulators and methods of use thereof
INTERCEPT PHARMACEUTICALS INC4 citations73
US9243027B2Jan 26, 2016
TGR5 modulators and methods of use thereof
INTERCEPT PHARMACEUTICALS INC5 citations73
US11034717B2Jun 15, 2021
Farnesoid X receptor modulators
INTERCEPT PHARMACEUTICALS INC3 citations72
US9777038B2Oct 3, 2017
Process for preparing bile acid derivatives
INTERCEPT PHARMACEUTICALS INC3 citations72
US11345721B2May 31, 2022
TGR5 modulators and methods of use thereof
INTERCEPT PHARMACEUTICALS INC2 citations68
US10800807B2Oct 13, 2020
TGR5 modulators and methods of use thereof
INTERCEPT PHARMACEUTICALS INC3 citations68
US11066437B2Jul 20, 2021
Methods and intermediates for the preparation of bile acid derivatives
INTERCEPT PHARMACEUTICALS INC2 citations65
US11000532B2May 11, 2021
Farnesoid x receptor modulators
INTERCEPT PHARMACEUTICALS INC0 citations63
US8969330B2Mar 3, 2015
Steroids as agonists for FXR
INTERCEPT PHARMACEUTICALS INC2 citations63
US10987362B2Apr 27, 2021
Treatment of fibrosis using FXR ligands
INTERCEPT PHARMACEUTICALS INC0 citations62
US9090652B2Jul 28, 2015
Bile acid derivatives as FXR ligands for the prevention or treatment of FXR-mediated diseases or conditions
INTERCEPT PHARMACEUTICALS INC3 citations62
US12291549B2May 6, 2025
Farnesoid X receptor modulators
INTERCEPT PHARMACEUTICALS INC0 citations61
US11319337B2May 3, 2022
3-desoxy derivative and pharmaceutical compositions thereof
INTERCEPT PHARMACEUTICALS INC0 citations61
US10815267B2Oct 27, 2020
3-desoxy derivative and pharmaceutical compositions thereof
INTERCEPT PHARMACEUTICALS INC1 citations61
PELLICCIARI ROBERTO
10 patentsUS8114862B2Feb 14, 2012
TGR5 modulators and methods of use thereof
PELLICCIARI ROBERTO13 citations93
US8058267B2Nov 15, 2011
Steroids as agonists for FXR
PELLICCIARI ROBERTO8 citations93
US7825129B2Nov 2, 2010
Thieno[2,3-c] isoquinolines for use as inhibitors of PARP
PELLICCIARI ROBERTO19 citations91
US6989388B2Jan 24, 2006
Thieno[2,3-c]iosquinolines for use as inhibitors of PARP
PELLICCIARI ROBERTO37 citations91
US8796249B2Aug 5, 2014
TGR5 modulators and methods of use thereof
PELLICCIARI ROBERTO13 citations84
US8445472B2May 21, 2013
TGR5 modulators and methods of use thereof
PELLICCIARI ROBERTO9 citations84
US8410083B2Apr 2, 2013
23-substituted bile acids as TGR5 modulators and methods of use thereof
PELLICCIARI ROBERTO9 citations84
US8546365B2Oct 1, 2013
Bile acid derivatives as FXR ligands for the prevention or treatment of FXR-mediated diseases or conditions
PELLICCIARI ROBERTO10 citations83
US8999964B2Apr 7, 2015
TGR5 modulators and methods of use thereof
PELLICCIARI ROBERTO6 citations73
US8299090B2Oct 30, 2012
Thiazolyl-and oxazolyl-isoquinolinones and methods for using them
PELLICCIARI ROBERTO3 citations61
GIULIANI SPA
4 patentsUS5061701AOct 29, 1991
Fluorinated bile acid derivatives, processes for the preparation thereof and pharmaceutical compositions containing them
GIULIANI SPA58 citations95
US5175320ADec 29, 1992
Fluorinated bile acid derivatives, processes for the preparation thereof and pharmaceutical compositions containing them
GIULIANI SPA39 citations92
US5057509AOct 15, 1991
Bile acid derivatives, processes for the preparation thereof and pharmaceutical compositions containing them
GIULIANI SPA26 citations92
US5166374ANov 24, 1992
Bile acid derivatives, processes for the preparation thereof and pharmaceutical compositions containing them
GIULIANI SPA3 citations62
GIPHARMEX SPA
2 patentsUS4892868AJan 9, 1990
Derivatives of biliary acids, process for the production thereof and corresponding pharmaceutical compositions
GIPHARMEX SPA52 citations93
US4921848AMay 1, 1990
Biliary acid derivatives, processes for the preparation thereof and pharmaceutical compositions containing them
GIPHARMEX SPA39 citations91
LEHNER AG
2 patentsUS4514393AApr 30, 1985
New derivatives of biliary acids, process for the production thereof and pharmaceutical compositions containing the same
LEHNER AG27 citations88
US4565810AJan 21, 1986
Derivatives of biliary acids, process for the production thereof and pharmaceutical compositions containing the same
LEHNER AG11 citations70
INTERCEPT PHARMACEUTICALS
1 patentFIORUCCI STEFANO
1 patentTES PHARMA S R L
1 patentSEARLE & CO
1 patentDEPHA TEAM SRL
1 patentFIDIA SPA
1 patentShowing the top 50 of 67 patents by PatentIndex Score.